1. Examine recently presented data as American Society of Clinical Oncology as it relates to the management of patients with upper GI or pancreatobiliary malignancies

2. Discuss any changes in standard of care

3. Summarize updates on ongoing clinical trials and future developments

4. Outline the benefit of 3 versus 6 months of FOLFOX/CAPEOX for adjuvant treatment of stage III colon cancer. 

5. Identify new treatment strategies for molecular subtypes of metastatic colorectal cancer. 

6. Summarize select Genitourinary Cancer trials presented at ASCO 2020

   7. Discuss practice changing implications of presented data

Attendees use this link to join the session:


Session date: 
09/09/2020 - 8:00am to 9:00am CDT
Clinical Science Center, G5/119
600 Highland Ave
Madison, WI 53792
United States
  • 1.00 ACPE Contact Hours - Pharmacist
  • 1.00 AMA PRA Category 1 Credit
  • 1.00 ANCC Contact Hours
  • 1.00 University of Wisconsin–Madison Continuing Education Hours

Please login or register to take this course.
Discloser List CME Internal Report
Dr. David Kosoff
Dr. Nataliya Uboha
Dr. Dustin Deming